Here are relevant reports on : age-detection-market
-
Latin America Enteral Feeding Devices Market by Type (Enteral Feeding, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding, Nasoduodenal), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Forecast to 2032
The Latin America Enteral Feeding Devices market, valued at USD 0.24 billion in 2025, stood at USD 0.25 billion in 2026 and is projected to advance at a resilient CAGR of 5.2% from 2026 to 2032, culminating in a forecasted valuation of USD 0.34 billion by the end of the period. The increase in the market is due to the growing cases of chronic and acute diseases that are difficult to manage without long-term nutritional support.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Continuous Renal Replacement Therapy Market by Product (Hemofilter, Bloodline, Machines, Dialysates), Modality (SCUF, CVVH, CVVHD, CVVHDF), Age (Adult, Pediatric), Enduser (Hospitals, Ambulatory), and Region - Global Forecast to 2028
The global continuous renal replacement therapy market, valued at US$1.3 billion in 2022, stood at US$1.4 billion in 2023 and is projected to advance at a resilient CAGR of 8.1% from 2023 to 2028, culminating in a forecasted valuation of US$2.1 billion by the end of the period. Various factors such as rise in worldwide prevalence of AKI, Growing number of ICU patients with AKI and rising incidences of sepsis, and growing clinical advantage of CRRT over intermittent blood purification are factors likely to accelerate the growth of the market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Europe Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer) - Forecast to 2030
The Europe telehealth & telemedicine market, valued at US$22.01 billion in 2024, stood at US$24.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$42.04 billion by the end of the period. The growth of the Europe telehealth & telemedicine market is driven by the rising demand for remote healthcare services, increasing adoption of digital health platforms, and expanding broadband and mobile connectivity across the region.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Blood Pressure Cuffs Market By Type (Automated, Manual), Size, Usage (Reusable, Disposable), Age Group (Adults, Infants & Children), Distribution Channel (Retail, Online), End User (Hospitals, Clinics, Homecare), Region-Global Forecast to 2032
The global blood pressure cuffs market, valued at US$0.6 billion in 2024, stood at US$0.7 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2032, culminating in a forecasted valuation of US$1.3 billion by the end of the period. This growth is primarily fueled by the expanding elderly population, which is at a higher risk of developing hypertension and associated cardiovascular complications.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. Some of the major players in this market include Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd. (India).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Age-related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029
The global age-related macular degeneration (AMD) drugs market, valued at US$9.55 billion in 2023, stood at US$10.46 billion in 2024 and is projected to advance at a resilient CAGR of 10.7% from 2024 to 2029, culminating in a forecasted valuation of US$17.37 billion by the end of the period. Factors such as the increase in the prevalence of AMD cases due to the changing lifestyle and dietary habits such as smoking, alcohol consumption, and lack of physical activity, a growing focus on research and development highlighted by steady development and approvals of AMD drugs along with improvements in reimbursement policies providing better and affordable access to therapeutic AMD drugs, supports the growth of this market.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Pulse Oximeter Market by Product (Equipment, Sensor), Type [Portable (Handheld, Wearable, Fingertip), Bedside], Technology (Conventional, Connected), Age Group (Adult, Infant, Neonatal), End User (Hospitals, Home Care), Region - Global Forecast to 2032
The global pulse oximeter market, valued at US$3.59 billion in 2024, stood at US$3.92 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2025 to 2032, culminating in a forecasted valuation of US$7.03 billion by the end of the period. The growth of this market is primarily driven by the rising prevalence of respiratory diseases, increasing prevalence of congenital heart disease (CHD) in children, a growing number of surgical procedures and hospitalizations, an increasing geriatric population, and subsequent rise in chronic diseases, technological advancements in pulse oximeter devices, growing investments in healthcare infrastructure, and the outbreak of infectious respiratory diseases.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (MAD), Tongue-Retaining Devices (TRD)), Purchase Type (Physician-prescribed), Gender (Male, Female), Age Group, Distribution Channel (Online, Retail) - Global Forecast to 2030
The global sleep apnea oral appliances market, valued at US$0.4B in 2024, is forecasted to grow at a 9.8% CAGR, reaching US$0.5B by 2025 and US$0.8B by 2030.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
US Enteral Feeding Devices Market by Type (Nasogastric Tubes, Administration Sets, Nasal Feeding, Nasoduodenal, Syringes, Connectors), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Forecast to 2032
The US enteral feeding device market, valued at US$1.13 billion in 2025, stood at US$1.19 billion in 2026 and is projected to advance at a resilient CAGR of 6.1% from 2026 to 2032, culminating in a forecasted valuation of US$1.70 billion by the end of the period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
US Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer, ASC) - Forecast to 2030
The US Telehealth & Telemedicine Market, valued at US$46.10 billion in 2024, stood at US$51.40 billion in 2025 and is projected to advance at a resilient CAGR of 10.2% from 2025 to 2030, culminating in a forecasted valuation of US$83.63 billion by the end of the period. In the US, permanent CMS reimbursement expansions and state-level payment parity laws are driving telehealth growth by securing fair, ongoing reimbursement comparable to in-person care.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
